Effective August 1st, 2026, all Generic Drugs being brought into the United States will continue to have a TARIFF of ZERO PERCENT for a two year period of time, after which the TARIFF will be raised to 100% for a one year period of time, and 200% thereafter. This is done in order to RESHORE Generic Pharmaceutical Production into America, with a penalty to those Companies that decide not to build Plant and Equipment within the stated period of time given to them. The objective of this Policy is to protect the people of the United States. The Policy on Patented, Branded, or Innovative Drugs, which has been so successful, will remain as is. Pharmaceutical Facilities are being built, at a level never seen before, all over the United States of America. Thank you for your attention to this matter! President DONALD J. TRUMP
🇨🇳 中文翻译
自2026年8月1日起,所有进入美国的仿制药将继续享有为期两年的零关税待遇,之后关税将提高至100%,为期一年,之后将提高至200%。这样做的目的是为了将仿制药生产重新带回美国,并对那些决定不在规定时间内在美国建立工厂和设备的公司进行惩罚。这项政策的目标是保护美国人民。已经非常成功的专利、品牌或创新药物政策将保持不变。制药设施正在以前所未有的水平在美国各地建设。感谢你对此事的关注!总统唐纳德·J·特朗普
1. 核心观点
特朗普宣布从2026年8月1日起,对进入美国的非专利药品实施两年零关税,之后关税将分别提高至100%和200%,以促使药品生产回流美国,并惩罚那些不在美国建厂的公司。
2. 美股影响(标普500 / 纳斯达克 /...
阅读完整解读 →